It is now being researched further, but apparently surgical mesh, when placed transvaginally can put women at a much higher risk for complications after surgery. According to the FDA this list of complications includes:
- Pain during sex
- Mesh erosion
- Vaginal scarring
- Bladder or bowel puncturing
- Urinary problems
- Urinary incontinence
The public was first was warned of the symptoms in a safety release by the FDA in 2008; this communicated the various complications that were arising in regards to this surgical procedure, especially in transvaginal placement of the mesh in women.
This caused the FDA to associate transvaginal mesh as a high risk solution in August 2011.
Many women that have faced complications are now seeking compensation for the negligence this manufacturer has shown in their failure to warn doctors and their patients about these issues with these types of procedures.